Central America vs Slovakia: Proportion of the target population who received a 3rd dose of
Central America
80.0%
in 2024
Slovakia
96.0%
in 2024
Central America rank
13th
Slovakia rank
16th
Proportion of the target population who received a 3rd dose of over time
- Central America
- Slovakia
How they compare
Slovakia currently reports 96.0% against 80.0% in Central America, a difference of 16.0%.
That makes Slovakia's figure about 1.2 times Central America's.
Across all 16 years both countries report, Slovakia has been ahead every year.
Central America ranks 13th and Slovakia ranks 16th of 37 groups.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central America | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 33.0% | 99.0% | 66.0% | Slovakia |
| 2010s | 86.5% | 97.3% | 10.8% | Slovakia |
| 2020s | 81.4% | 96.2% | 14.8% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Central America or Slovakia?
- Slovakia, at 96.0% against 80.0% in Central America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Central America and Slovakia?
- 16.0%, with Slovakia ahead.
- How many years of comparable data are there for Central America and Slovakia?
- 16 years are reported by both, from 2009 to 2024.
- How do Central America and Slovakia rank globally for proportion of the target population who received a 3rd dose of?
- Central America ranks 13th and Slovakia ranks 16th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.